Supplemental material
Open access
4,020
Views
6
CrossRef citations to date
0
Altmetric
Report
Engineering death resistance in CHO cells for improved perfusion culture
Michael A. MacDonalda ARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St. Lucia, Australia;b Thermo Fisher Scientific, Woolloongabba, Brisbane, Australia
https://orcid.org/0000-0002-2123-096XView further author information
Matthias Nöbela ARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St. Lucia, Australia;b Thermo Fisher Scientific, Woolloongabba, Brisbane, Australia
https://orcid.org/0000-0001-6996-6776View further author information
Verónica S. Martíneza ARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St. Lucia, AustraliaView further author information
, Kym Bakerb Thermo Fisher Scientific, Woolloongabba, Brisbane, AustraliaView further author information
, Evan Shaveb Thermo Fisher Scientific, Woolloongabba, Brisbane, AustraliaView further author information
, Peter P. Graya ARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St. Lucia, AustraliaView further author information
, Stephen Mahlera ARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St. Lucia, Australia
https://orcid.org/0000-0003-2403-1437View further author information
Trent Munroa ARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St. Lucia, Australia;c National Biologics Facility, The University of Queensland, Saint Lucia, Queensland, Australia
https://orcid.org/0000-0003-1987-2020View further author information
Lars K. Nielsena ARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St. Lucia, Australia;d Queensaldn Metabolomics and Proteomics, The University of Queensland, Saint Lucia, Queensland, Australia;e The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, DenmarkView further author information
& Esteban Marcellina ARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St. Lucia, Australia;d Queensaldn Metabolomics and Proteomics, The University of Queensland, Saint Lucia, Queensland, AustraliaCorrespondence[email protected]
https://orcid.org/0000-0003-3173-7956View further author information
Article: 2083465
|
Received 30 Nov 2021, Accepted 24 May 2022, Published online: 23 Jun 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.